<div id="readability-page-1"><p>RBC Capital analyst Ben Hendrix maintained a Buy rating on Addus Homecare yesterday and set a price target of $139.00.</p><h3>Claim 50% Off TipRanks Premium and Invest with Confidence </h3><ul><li>Unlock  hedge-fund level data  and  powerful investing tools  designed to help you make smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  so your portfolio is always positioned for maximum potential</li></ul> <p>Hendrix covers the Healthcare sector, focusing on stocks such as CVS Health, Brookdale Senior Living, and Select Medical. According to TipRanks, Hendrix has an average return of <span>4.6%</span> and a 51.76% success rate on recommended stocks. </p> <p>In addition to RBC Capital, Addus Homecare also received a Buy from Bank of America Securities’s Joanna Gajuk in a report issued on December 10. However, on December 3, BMO Capital maintained a Hold rating on Addus Homecare (NASDAQ: ADUS).</p></div>

ADUS

<p>RBC Capital analyst Ben Hendrix maintained a Buy rating on Addus Homecare with a price target of $139.00. Hendrix, who covers the Healthcare sector, has an average return of 4.6% and a 51.76% success rate. Addus Homecare also received a Buy rating from Bank of America Securities, while BMO Capital maintained a Hold rating.</p>

Addus Homecare (ADUS) Gets a Buy from RBC Capital